Evaluate the Value of Telehomecare for Diabetes

NACompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Type 2 Diabetes
Interventions
DEVICE

BlueStar app

BlueStar is a smart-phone enabled application that is designed to serve as a virtual coach for patients. The app sends daily evidence-based, real-time messages as well as longitudinal feedback on how to improve diabetes management. The Bluestar app has been shown to be effective at teaching patients about dietary impacts on their blood glucose levels, encouraging patients to generate higher-quality blood glucose data for enhanced self-monitoring, and to improve overall management of diabetes as represented by reductions in levels of HgbA1c. Benefits have been demonstrated in time periods as brief as three months. One US based study showed a decrease in hospitalizations and emergency department visits among participants who use the application.

Trial Locations (1)

M5S 1B2

Women's College Hospital, Toronto

All Listed Sponsors
collaborator

North York General Hospital

OTHER

collaborator

William Osler Health System

OTHER

collaborator

St. Joseph's Care Group

OTHER

collaborator

Ontario Telemedicine Network (OTN)

UNKNOWN

collaborator

Unity Health Toronto

OTHER

lead

Women's College Hospital

OTHER

NCT02813343 - Evaluate the Value of Telehomecare for Diabetes | Biotech Hunter | Biotech Hunter